MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

OncoSec Medical Company Profile (NASDAQ:ONCS)

Consensus Ratings for OncoSec Medical (NASDAQ:ONCS) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $17.00 (942.94% upside)

Analysts' Ratings History for OncoSec Medical (NASDAQ:ONCS)
Show:
DateFirmActionRatingPrice TargetActions
6/6/2016Maxim GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2016HC WainwrightReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for OncoSec Medical (NASDAQ:ONCS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
6/9/2016        
6/9/2016Q316($0.43)($0.37)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2016Q216($0.46)($0.42)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/8/2015Q116($0.48)($0.47)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/14/2015Q415($0.40)($0.48)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2015($0.02)($0.02)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/8/2014($0.02)($0.02)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/13/2014($0.01)($0.01)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/16/2014($0.01)($0.02)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for OncoSec Medical (NASDAQ:ONCS)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.43)($0.43)($0.43)
Q2 20161($0.44)($0.44)($0.44)
Q3 20161($0.45)($0.45)($0.45)
(Data provided by Zacks Investment Research)
Dividend History for OncoSec Medical (NASDAQ:ONCS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for OncoSec Medical (NASDAQ:ONCS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
10/16/2015Punit DhillonCEOBuy10,000$4.25$42,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2015Punit DhillonCEOBuy2,500$6.74$16,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/20/2014Anthony E Maida IIIDirectorBuy22,800$0.81$18,468.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2014Punit DhillonCEOBuy50,000$0.80$40,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for OncoSec Medical (NASDAQ:ONCS)
DateHeadline
06/18/16 09:51 AMRevenue Update on OncoSec Medical Inc(NASDAQ:ONCS) - TheFounders Daily
06/18/16 09:51 AMCompany Update (NASDAQ:ONCS): OncoSec Medical Inc Presents Preliminary Findings from Head and Neck Phase II ... - Smarter Analyst
06/16/16 05:52 PMBiotechs Setup To Bounce Once Again
06/16/16 09:39 AMOncoSec Presents Preliminary Findings from Head and Neck Phase II Clinical Trial at EUROGIN 2016 Conference - [at noodls] - SAN DIEGO, June 16, 2016 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today presented preliminary findings ...
06/09/16 03:19 PMOncoSec Announces Third Quarter and YTD Results for Fiscal Year 2016 - [at noodls] - SAN DIEGO, June 9, 2016 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced key corporate objectives ...
06/08/16 06:01 PMColony Capital, Inc. (NYSE:CLNY) Rose 2.96%: OncoSec Medical Incorporated (NASDAQ:ONCS), PetMed Express ... - KC Register
06/06/16 05:34 PMOncosec Medical (ONCS) Shows Utility of T-cell Exhaustion Marker to Predict Response to Anti-PD-1 Monotherapies - StreetInsider.com
06/06/16 09:21 AMOncoSec Medical : Collaborators Present Results of Novel T-Cell Exhaustion Marker to Predict Response to Anti-PD-1 Monotherapy
06/06/16 05:28 AMOncoSec Collaborators Present Results of Novel T-Cell Exhaustion Marker to Predict Response to Anti-PD-1 Monotherapy - [at noodls] - SAN DIEGO, June 6, 2016 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that its collaborators ...
06/03/16 06:08 PMOncoSec Medical Incorporated's CEO Punit Dhillon Interviewed by The Life Sciences Report - Yahoo Finance UK
06/03/16 08:31 AMStock Review and Earnings Check on OncoSec Medical Inc (NASDAQ:ONCS) - HNN - Stock Review and Earnings Check on OncoSec Medical Inc (NASDAQ:ONCS)HNNCompany earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting OncoSec Medical Inc (NASDAQ:ONCS) to report quarterly EPS of $-0.43. The company's next earnings report is expected to be published on ...and more »
06/02/16 06:01 PMBroker Watchlist: OncoSec Medical (ONCS) - Share Trading News - Broker Watchlist: OncoSec Medical (ONCS)Share Trading NewsOncoSec Medical Incorporated is a biotechnology company focused on designing, developing and commercializing gene therapies, therapeutics and medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer.OncoSec Medical Incorporated's CEO Punit Dhillon Interviewed by The Life Sciences ReportMarketwired (press release)all 5 news articles »
06/02/16 09:57 AMOncoSec Medical Incorporated's CEO Punit Dhillon Interviewed by The Life Sciences Report - [Marketwired] - Cancer patients often receive multiple rounds of chemotherapy, with new drugs incorporated into treatment programs as tumors develop resistance. OncoSec Medical Incorporated's Punit Dhillon describes ...
06/02/16 08:36 AMOncoSec Medical Inc's Stock Formed A Several Months Bearish Multiple Bottom - HNN - OncoSec Medical Inc's Stock Formed A Several Months Bearish Multiple BottomHNNThe stock of OncoSec Medical Inc (ONCS) shows a multiple bottoms pattern with $1.60 target or 13.00% below today's $1.84 share price. The 8 months chart pattern indicates high risk for the $33.02 million company. It was reported on Jun, 2 by Finviz.com.
06/01/16 05:23 AMOncoSec to Present at Scientific and Investment Conferences in June - [at noodls] - SAN DIEGO, June 1, 2016 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that members of its ...
05/31/16 09:30 AMShare Rating Focus on OncoSec Medical Inc (NASDAQ:ONCS) - HNN - Share Rating Focus on OncoSec Medical Inc (NASDAQ:ONCS)HNNThis stock research may entail following what professional equity analysts think about the company. Presently, Wall Street analysts have given a consensus stock rating of 1 on shares of OncoSec Medical Inc (NASDAQ:ONCS). Covering analysts will ...and more »
05/28/16 02:24 AMStock Update (NASDAQ:ONCS): OncoSec Medical Inc Closes $10 Million At-The-Market Registered Direct Offering - Smarter Analyst - Stock Update (NASDAQ:ONCS): OncoSec Medical Inc Closes $10 Million At-The-Market Registered Direct OfferingSmarter AnalystOncoSec Medical Inc (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that it has closed its previously announced at-the-market registered direct offering with a single healthcare dedicated ...and more »
05/26/16 07:37 PMOncoSec Closes $10 Million At-The-Market Registered Direct Offering - [at noodls] - SAN DIEGO, May 26, 2016 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that it has closed its ...
05/24/16 04:22 PMONCOSEC MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secur -
05/22/16 12:20 PMFriday's Mid-Day Movers: Linn Energy (LINE), Breitburn Energy Partners (BBEP), OncoSec Medical Inc (ONCS ... - Analyst Ratings - Friday's Mid-Day Movers: Linn Energy (LINE), Breitburn Energy Partners (BBEP), OncoSec Medical Inc (ONCS ...Analyst RatingsSo far Friday, May 20, NASDAQ is up 1.48% and the S&P is up 0.84%. Let's take a look at this mornings' most active stocks and the relevant expert activity. Linn Energy (NASDAQ:LINE), Breitburn Energy Partners (NASDAQ:BBEP), OncoSec Medical Inc ...and more »
05/18/16 09:26 PMOncoSec to Host Third Quarter Financial Results Conference Call on June 9, 2016 - PR Newswire (press release) - OncoSec to Host Third Quarter Financial Results Conference Call on June 9, 2016PR Newswire (press release)SAN DIEGO, May 18, 2016 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that the Company will host its fiscal third quarter 2016 ...and more »
05/17/16 07:21 PMMorning Watch List: Prologis, Inc. (NYSE:PLD), OncoSec Medical Incorporated (NASDAQ:ONCS), MannKind Corp ... - KC Register - Morning Watch List: Prologis, Inc. (NYSE:PLD), OncoSec Medical Incorporated (NASDAQ:ONCS), MannKind Corp ...KC RegisterPrologis, Inc. (NYSE:PLD) is 0.61% away from its 52 week high and its 52 week range is $35.25 – 48.18. OncoSec Medical Incorporated (NASDAQ:ONCS)'s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a note issued to ...and more »
05/11/16 10:00 PMOncosec Medical (NASDAQ:ONCS) Short Interest Increased By 14.56% - B.O.D.Y Confidential - Oncosec Medical (NASDAQ:ONCS) Short Interest Increased By 14.56%B.O.D.Y ConfidentialThe short interest to Oncosec Medical's float is 2.12%. The stock increased 0.60% or $0.01 on May 11, hitting $1.67. About 53,896 shares traded hands. OncoSec Medical Inc (NASDAQ:ONCS) has declined 60.66% since October 5, 2015 and is downtrending.
05/05/16 10:07 PMEarnings Outlook on OncoSec Medical Inc (NASDAQ:ONCS) - B.O.D.Y Confidential - Earnings Outlook on OncoSec Medical Inc (NASDAQ:ONCS)B.O.D.Y ConfidentialAnalysts and investors will be anticipating OncoSec Medical Inc (NASDAQ:ONCS)'s next earnings release which is expected to be posted on or around 2016-06-14. Sell-side research firms on Wall Street are expecting that the company will post EPS of $-0.43 ...and more »
05/03/16 12:27 AMOncosec Medical (NASDAQ:ONCS) Shorted Shares Increased By 14.56% - B.O.D.Y Confidential - Oncosec Medical (NASDAQ:ONCS) Shorted Shares Increased By 14.56%B.O.D.Y ConfidentialThe short interest to Oncosec Medical's float is 2.12%. The stock is down 4.59% or $0.09 after the news, hitting $1.87 per share. About 75,850 shares traded hands. OncoSec Medical Inc (NASDAQ:ONCS) has declined 71.01% since September 24, 2015 and ...Broker Outlook For The Week Ahead: OncoSec Medical (ONCS)Share Trading Newsall 2 news articles »
05/03/16 12:27 AMShining on Major News: OncoSec Medical Incorporated (NASDAQ:ONCS), Chimera Investment Corporation (NYSE ... - KC Register - Shining on Major News: OncoSec Medical Incorporated (NASDAQ:ONCS), Chimera Investment Corporation (NYSE ...KC RegisterOn 19 April, OncoSec Medical Incorporated (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, presented long-term, follow-up data of patients who were treated with its investigational therapy ImmunoPulse™ IL-12 ...and more »
04/27/16 09:59 PMOncoSec Medical Inc (NASDAQ:ONCS) Wall Street Rating in Focus - News Tribune - OncoSec Medical Inc (NASDAQ:ONCS) Wall Street Rating in FocusNews TribuneZacks.com, founded by Len Zacks, a Mathematics Ph.D. from M.I.T. who discovered that earnings estimate revisions are the most powerful force impacting stock prices, track 4 equity research firms that cover shares of OncoSec Medical Inc (NASDAQ:ONCS).and more »
04/26/16 08:24 PMOncoSec Medical Inc (NASDAQ:ONCS) Share Rating Recap - B.O.D.Y Confidential - OncoSec Medical Inc (NASDAQ:ONCS) Share Rating RecapB.O.D.Y ConfidentialShares of OncoSec Medical Inc (NASDAQ:ONCS) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from ...
04/26/16 05:12 AMIs OncoSec Medical Inc a Sell? The Stock Declines Again - The Post - Is OncoSec Medical Inc a Sell? The Stock Declines AgainThe PostThe stock of OncoSec Medical Inc (NASDAQ:ONCS) is a huge mover today! The stock is down 7.46% or $0.18 after the news, hitting $2.22 per share. About 347,506 shares traded hands. OncoSec Medical Inc (NASDAQ:ONCS) has declined 61.97% since ...OncoSec Medical (ONCS) Updated Analyst CoverageRisers & Fallersall 2 news articles »
04/26/16 05:12 AMStock Shooting Lower Today: OncoSec Medical Incorporated (NASDAQ:ONCS) - The Post - Stock Shooting Lower Today: OncoSec Medical Incorporated (NASDAQ:ONCS)The PostOncoSec Medical Incorporated (NASDAQ:ONCS) was a top loser in today's session as the company saw shares drop -8.67% on the day at the time of writing. Stocks whose market prices drop the most during the trading day are bluntly referred to as losers.and more »
04/22/16 05:25 AMHot stocks Update: Repros Therapeutics Inc. (NASDAQ:RPRX) , OncoSec Medical Incorporated (NASDAQ:ONCS) - Is stories - Is storiesHot stocks Update: Repros Therapeutics Inc. (NASDAQ:RPRX) , OncoSec Medical Incorporated (NASDAQ:ONCS)Is storiesRepros Therapeutics Inc. (NASDAQ:RPRX) decreased -8.63% to $2.86 while traded 5.04 million shares on 4/20/2016. The stock price negotiated for value between $2.80 to $3.04 in recent trading session. During the past 52 weeks, the stock's price witnessed ...and more »
04/21/16 05:18 AMHere's Why OncoSec Medical Inc (ONCS) Stock Is in the Green Today - Bidness ETC - Bidness ETCHere's Why OncoSec Medical Inc (ONCS) Stock Is in the Green TodayBidness ETCOncoSec Medical Inc. (NASDAQ:ONCS) stock gained as much as 38.59% during the early trading hours today, based on the positive data for ImmunoPulse interleukin-12 (IL-12) — an investigational therapy — presented by the company, last evening.Heat Biologics, Inc. (NASDAQ:HTBX), OncoSec Medical, Inc. (NASDAQ:ONCS) Present Initial Data at the AACR ...Journal TranscriptNoticeable Stocks: OncoSec Medical Inc (NASDAQ:ONCS), Manhattan Associates, Inc. (NASDAQ:MANH), Intrepid ...The Point ReviewReal-Time Stocks Update: OncoSec Medical Inc (ONCS), GoPro Inc (GPRO)News OracleSonoran Weekly Review -Share Trading News -Nasdaqall 10 news articles »
04/20/16 05:44 AMHeat Biologics, Inc. (NASDAQ:HTBX), OncoSec Medical, Inc. (NASDAQ:ONCS) Present Initial Data at the AACR ... - Journal Transcript - Journal TranscriptHeat Biologics, Inc. (NASDAQ:HTBX), OncoSec Medical, Inc. (NASDAQ:ONCS) Present Initial Data at the AACR ...Journal Transcript... (AACR) Annual Meeting, immuno-oncology company Heat Biologics, Inc. (NASDAQ:HTBX) has presented the preclinical results from its team-up with DNA-based intratumoral cancer immunotherapy company OncoSec Medical, Inc. (NASDAQ:ONCS), which ...OncoSec Medical Adds 3%, Presents Positive Melanoma Clinical Data (NASDAQ:ONCS)Sonoran Weekly ReviewLatest Analyst Ratings For OncoSec Medical (ONCS)Share Trading Newsall 3 news articles »
04/19/16 11:34 PMOncosec Medical (ONCS) Announces Presentation of Positvie ImmunoPulse IL-12 Data in Treating Melanoma - StreetInsider.com - Oncosec Medical (ONCS) Announces Presentation of Positvie ImmunoPulse IL-12 Data in Treating MelanomaStreetInsider.comOncoSec Medical Incorporated (NASDAQ: ONCS) presented long-term, follow-up data of patients who were treated with its investigational therapy ImmunoPulse IL-12 and later went on to receive an anti-PD-1/PD-L1 therapy. These data suggest that ...OncoSec Medical Adds 3%, Presents Positive Melanoma Clinical Data (NASDAQ:ONCS)Sonoran Weekly Reviewall 2 news articles »
04/19/16 04:12 PMOncoSec Presents Positive Melanoma Clinical Data at American Association for Cancer Research (AACR) Annual Meeting 2016 - [at noodls] - SAN DIEGO, April 19, 2016 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today presented long-term, follow-up ...
04/19/16 03:46 PMONCOSEC MEDICAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
04/19/16 05:29 AMOncoSec Medical Inc (NASDAQ:ONCS) Analyst Rating Review - Clinton Financial - OncoSec Medical Inc (NASDAQ:ONCS) Analyst Rating ReviewClinton FinancialCovering analysts typically give Buy, Sell and Hold recommendations along with guidance and company earnings projections. Currently, there are 4 analysts that have provided ratings for OncoSec Medical Inc (NASDAQ:ONCS). 4 have rated the stock a ...and more »
04/18/16 09:00 AMONCS: New Data Provide Evidence that ImmunoPulse IL-12 Can Prime the Immune System -
04/15/16 03:56 PMONCOSEC MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financia -
04/15/16 03:27 PMOncoSec Announces New Senior Leadership Responsibilities - [at noodls] - SAN DIEGO, April 15, 2016 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced leadership changes ...
04/15/16 08:37 AMEarnings Watch on OncoSec Medical Inc (NASDAQ:ONCS) - RiversideGazette.com - Earnings Watch on OncoSec Medical Inc (NASDAQ:ONCS)RiversideGazette.comOncoSec Medical Inc (NASDAQ:ONCS) has a consensus earnings per share estimate for the current quarter of $-0.43 based on compiled analyst projections. The company is next expected to release earnings on or around 2016-06-14 for the period ending ...
04/13/16 10:06 PMOncoSec Medical Inc (NASDAQ:ONCS): Quick Look at Earnings - News Tribune - OncoSec Medical Inc (NASDAQ:ONCS): Quick Look at EarningsNews TribuneWhen OncoSec Medical Inc (NASDAQ:ONCS) issues their next quarterly report on or near 2016-06-14, Wall Street analysts are predicting they will report earnings per share of $-0.43. This consensus EPS number is provided by Zacks Research, which might ...Today OncoSec Medical Inc Stock RisesFranklin IndependentOncosec Medical (NASDAQ:ONCS) Shorted Shares Increased By 0.19%Business Standard TribuneOncoSec Medical Shares Rise 8% Pre-Bell to Provide Overview, Discussion of Melanoma Clinical Data (NASDAQ ...Sonoran Weekly ReviewPR Newswire (press release)all 5 news articles »
04/12/16 11:03 PMView on Ratings OncoSec Medical Inc (NASDAQ:ONCS) - Business Standard Tribune - View on Ratings OncoSec Medical Inc (NASDAQ:ONCS)Business Standard TribuneUsing a scale from 1 to 5, OncoSec Medical Inc (NASDAQ:ONCS) has a rating of 1 on the stock. A score of 1 or 2 indicates a Buy rating, and a score of 4 or 5 indicates a Sell rating. A 3 would indicate a Hold. This consensus number is made up of ...OncoSec Medical (ONCS) Latest Broker CoverageRisers & FallersOncoSec Announces Poster Presentation with Heat Biologics, Inc. at the American Association for Cancer Research ...PR Newswire (press release)all 3 news articles »
04/12/16 03:22 AMOncoSec Medical Inc (NASDAQ:ONCS) Analyst Recommendation Outlook - Clinton Financial - OncoSec Medical Inc (NASDAQ:ONCS) Analyst Recommendation OutlookClinton FinancialCovering analysts usually give Buy, Sell and Hold recommendations along with guidance and company earnings estimates. There are 4 analysts providing ratings for OncoSec Medical Inc (NASDAQ:ONCS). 4 have given the stock a “Strong Buy”, 0 rate it a ...and more »
04/09/16 07:54 AMOncosec Medical (NASDAQ:ONCS) Shorted Shares Increased 0.19% After Market Selling - Clinton Financial - Oncosec Medical (NASDAQ:ONCS) Shorted Shares Increased 0.19% After Market SellingClinton FinancialThe short interest to Oncosec Medical's float is 1.06%. The stock decreased 1.63% or $0.04 on April 8, hitting $2.42. About 32,168 shares traded hands. OncoSec Medical Inc (NASDAQ:ONCS) has declined 57.37% since September 1, 2015 and is ...Upgrades And Downgrades For OncoSec Medical (ONCS)Risers & Fallersall 2 news articles »
04/07/16 08:46 AMSabby Management buys $2.7 Million stake in OncoSec Medical Inc (ONCS) - The Sussex Pilot - Sabby Management buys $2.7 Million stake in OncoSec Medical Inc (ONCS)The Sussex PilotOncoSec Medical Inc (ONCS) : Sabby Management scooped up 884,190 additional shares in OncoSec Medical Inc during the Q4 period, according to a recent disclosure to the SEC. The investment management firm now holds a total of 1,224,359 shares of ...and more »
11/19/15 05:14 AMOncoSec to Host First Quarter Financial Results Conference Call on December 8, 2015 - [at noodls] - SAN DIEGO, Nov. 19, 2015 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that the Company will ...
11/09/15 03:26 PMOncoSec Medical Closes $7.5 Million Registered Direct Offering - [at noodls] - SAN DIEGO, Nov. 9, 2015 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that the Company has ...
11/03/15 07:17 PMOncoSec Announces $7.5 Million Registered Direct Offering - [at noodls] - SAN DIEGO, Nov. 3, 2015 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that it has entered ...
10/29/15 05:28 AMOncoSec Enrolls First Patient in Biomarker-Focused Pilot Study in Triple Negative Breast Cancer - [at noodls] - SAN DIEGO, Oct. 29, 2015 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that the Company has ...
About OncoSec Medical

OncoSec Medical logoOncoSec Medical Incorporated is a biotechnology company focused on designing, developing and commercializing gene therapies, therapeutics and medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer. The Company's portfolio includes biologic immunology therapeutic product candidates intended to treat a range of tumor types. The Company's technology includes property relating to its ImmunoPulse delivery technology. The Company's ImmunoPulse is an electroporation delivery device that the Company uses in combination with its therapeutic product candidates, including deoxyribonucleic acid (DNA) plasmids that encode for immunologically active agents, to deliver the therapeutic directly into the tumor and promote an inflammatory response against the cancer. Its electroporation devices consist of an electrical pulse generator and disposable applicators. The Company's ImmunoPulse product candidates are based on its DNA based immunotherapy technology.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ONCS
  • CUSIP:
Key Metrics:
  • Previous Close: $1.60
  • 50 Day Moving Average: $1.69
  • 200 Day Moving Average: $2.02
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $28.75M
  • Current Quarter EPS Consensus Estimate: $-1.56 EPS
Additional Links:
OncoSec Medical (NASDAQ:ONCS) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha